Latest News & Features
Refine Search
Americas
A Delaware jury unanimously sided with Sanofi-owned biotech Inhibrx, clearing it of trade secrets misappropriation claims. Amy Candido of Wilson Sonsini shares insights into the defence strategy that led to the win. 16 December 2024
Americas
Obviousness-type double patenting can pose a significant challenge, as it can lead to unfair extensions of patent rights, and limit other’s abilities to build upon inventions, hindering further innovation. 15 December 2024
Americas
Firm expands its Mechanical & Electromechanical Technologies Practice with latest addition | Partner brings nearly two decades of experience in IP strategy, litigation, and transactions | Experience in biotechnology, medical devices, and blockchain. 12 December 2024
Europe
Paris Local Division revokes Dexcom patent and dismisses infringement action against rival | UPC revoked two other patents belonging to medical device company earlier in 2024. 12 December 2024
Americas
With 27 witnesses, plus both patent infringement and misappropriation claims, lead counsel for Insulet Alexandra Valenti and Scott Bluni share ‘a milestone’ in DTSA case law. 12 December 2024
Americas
BlueAllele “plausibly alleged” that some of Intellia’s uses of technology were not reasonably related to FDA approval | Biotech claimed competitor received over $100m from Regeneron for using innovation to research therapeutic candidates. 10 December 2024
Americas
Corporate legal teams can embrace the AI revolution by encouraging experimentation and managing risks proactively, according to a recent panel featuring leading pharma counsel. 10 December 2024
Americas
As President-elect Donald Trump prepares for his second term, the life sciences industry is calling for predictability, finds Marisa Woutersen. 5 December 2024
Americas
Jury finds medical device company misappropriated secrets covering Insulet’s Omnipod l Insulet “extremely pleased” with verdict l Federal circuit overturned ban on EOFlow’s product in June. 5 December 2024
Americas
European Supplementary Protection Certificates (SPCs) are very different to US PTEs in several key respects. In this seminar, we'll run through strategies to secure maximal protection for approved pharmaceutical & biologic products in Europe. 4 December 2024